Related Experiment Video
Updated: Jan 5, 2026

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV
Published on: October 1, 2007
CD4+ versus CD8+ T-lymphocyte identification in an integrated microfluidic chip using light scattering and machine
Domenico Rossi1, David Dannhauser1, Mariarosaria Telesco1
1Center for Advanced Biomaterials for Healthcare@CRIB, Istituto Italiano di Tecnologia (IIT), Largo Barsanti e Matteucci 53, 80125 Naples, Italy.
Insights
A novel label-free method uses light scattering and machine learning to differentiate CD4+ and CD8+ T lymphocytes. This biophysical approach offers a promising tool for clinical diagnostics and monitoring immune status, including HIV progression.
Area of Science:
- Immunology
- Biophysics
- Microfluidics
Background:
- T lymphocytes, specifically CD4+ and CD8+ subclasses, are crucial for adaptive immunity.
- Current methods for T lymphocyte characterization rely on complex antibody-based cytometric assays.
- Distinguishing between CD4+ and CD8+ T cells is vital for clinical decision-making.
Purpose of the Study:
- To develop a label-free, biophysical method for distinguishing and counting CD4+ and CD8+ T lymphocytes at the single-cell level.
- To leverage integrated microfluidics and data mining for accurate cell analysis.
- To assess the potential of this approach for clinical applications.
Main Methods:
- Utilized a microfluidic chip for single-cell optical analysis in viscoelastic fluids.
- Measured biophysical properties including cell dimensions, nuclear refractive index, and cytosol refractive index.
- Employed machine learning algorithms to analyze measured properties and classify T lymphocyte subclasses.
Main Results:
- Achieved 79% accuracy in distinguishing and counting CD4+ and CD8+ T cells using biophysical properties and machine learning.
- Enhanced identification accuracy to 88% by stimulating cells with an anti-apoptotic protein, increasing biophysical differences.
- Validated the approach using samples reflecting physiological and pathological CD4+/CD8+ ratios.
Conclusions:
- The developed light-scattering and machine learning approach provides an effective label-free method for T lymphocyte subclass identification.
- This technique shows significant potential for integration into hematological clinical routines and disease monitoring, such as HIV progression.
- Further research can optimize this biophysical evaluation for broader diagnostic applications.
Abstract:
T lymphocytes are a group of cells representing the main effectors of human adaptive immunity. Characterization of the most representative T-lymphocyte subclasses, CD4+ and CD8+, is challenging, but has a significant impact on clinical decisions. Up to now, T lymphocytes have been identified by quite complex cytometric assays, which are based on antibody labeling. However, a label-free approach based on pure biophysical evaluation at a single-cell level could enable the ability to distinguish between these subclasses. Here, we report a light-scattering approach, supported by accurate data mining, to evaluate cell biophysical properties on an integrated microfluidic chip. In order to perform single-cell optical analysis in viscoelastic fluids, such a chip is composed of mixing, alignment, readout and collection sections. In particular, we measured the cell dimensions, the refractive index of the cell nucleus, the refractive index of the cytosol, and the nucleus-to-cytosol ratio. Combining measurement of biophysical properties and machine learning allows us to both distinguish and count human CD4+ and CD8+ cells with an accuracy of 79%. An enhanced identification accuracy of 88% can be achieved by stimulating the cells with a selective anti-apoptotic protein, which results in increased biophysical differences between CD4+ and CD8+ cells. This approach has been successfully validated by analysis of samples that recapitulate physiological and pathological scenarios (CD4+/CD8+ ratios). The results are encouraging for the possible application of our approach in hematological clinical routines, as well as in diagnosis and follow-up of specific pathologies, such as human immunodeficiency virus (HIV) progression.

